FBTCX Mutual Fund

FBTCX Mutual Fund (Fidelity Advisor Biotechnology Fund Class C) is managed by Fidelity Investments (US) with $67.3M in net assets. FBTCX expense ratio is 1.71%, holding 92 positions across sectors including Health Care, Financials. Inception date: 2000-12-27.

FBTCX performance shows a YTD return of 21.02%. The 1-year return is 61.57% and the 5-year return is 11.74%. FBTCX dividend yield stands at 1.12%, paid annually.

FBTCX top holdings include Abbvie Inc. (16.6%), Gilead Sciences (6.6%), Alnylam Pharmaceuticals Inc. (5.0%), Ascendis Pharma A/S (4.5%), Cogent Biosciences Inc (3.8%). Go to all FBTCX holdings, FBTCX sectors, or FBTCX dividends.

FBTCX can be compared against other funds. Use FBTCX overlap to find shared positions, or FBTCX vs another fund for a side-by-side view. FBTCX alternatives are available via the screener, along with tax-loss harvesting opportunities.